Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cutaneous Phosphorylated Alpha-Synuclein for Detection of Prodromal Synucleinopathies

NCT05757206 is registered in ClinicalTrials.gov with CND Life Sciences as lead sponsor.

NCT NCT05757206
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05757206 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cutaneous Phosphorylated Alpha-Synuclein for Detection of Prodromal Synucleinopathies
Lead sponsor
CND Life Sciences
Phase
Observational
Overall status
Active, not recruiting
Start date
September 15, 2022
Completion date
December 31, 2025
Enrollment
80 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

rem sleep behavior disorder (irbd)